MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Companies: Acquiring (M&A)
HepaLife Technologies
Parents
*Architects: Trauma, Blood, Wound Healing, Military Medicine, Combat Casualty Care & Emergency Medicine
Companies: Acquiring (M&A)
Children
Aquamed™
As part of the new firm's launch, HepaLife named AquaMed CEO Matt Harriton to be Alliqua's chief executive.
HepaLife in May 2010 acquired AquaMed Technologies Inc., which makes hydrogels used for transdermal drug delivery, in an all-stock deal valued at about $16 million.
HepaLife Technologies Inc. (OTC:HPLF) formed a new subsidiary to launch its existing transdermal drug delivery and wound care technologies into new markets.(2010)
HepaLife's product offering includes biomedical products focused on the development and manufacturing of both drug delivery and liver health technologies.
New York City, New York
The company said AquaMed's 16,500 square foot cGMP compliant, Food & Drug Administration-registered, facility is "crucial in helping Alliqua meet its strategic growth objectives."
The new business, Alliqua BioMedical Inc., will develop and manufacture its own proprietary products